Clinical Trial Update: Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing recombinant human growth hormone during rehabilitation after traumatic brain injury has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Recombinant human growth hormone (somatropin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Traumatic Brain Injury | Phase 2 | Status: COMPLETED | Results posted: 2019-11-18